MREO:NASDAQ, Mereo BioPharma Group plc

MREO stock overview

Mereo BioPharma Group plc (MREO:NASDAQ) closed at $0.277 on November 17, 2026, down 9.11% on the day. The stock trades 88.3% below its 52-week high of $2.37 and 38.6% above its 52-week low of $0.200. Over the past year, it lost 82.8%. Mereo BioPharma Group plc is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$0.277
Day change
-9.11%
Volume
945,605
Average volume
1,235,407
Market cap
44M+
52-week range
$0.200 – $2.37
50-day average
$0.311
200-day average
$0.321

Price action over the past year

In 252 trading sessions since November 14, 2025, MREO closed higher on 107 days (42%). Its best day was December 30, 2025 (+30.18%) and its worst was December 29, 2025 (-87.66%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

MREO news

About Mereo BioPharma Group plc

Mereo BioPharma Group PLC was incorporated and registered in England and Wales under the name Mereo BioPharma Group Limited on March 10, 2015. On June 3, 2016, the Company re-registered as a public company and changed its name to Mereo BioPharma Group PLC. The Company is a speciality biopharmaceutical company. The Company is principally engaged in the research and development of novel pharmaceuticals.

Similar stocks

Find more stocks like MREO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.